{"transactions":[{"id":2111009,"issuer":{"id":7145,"kind":"organization","name":"Celularity Inc","symbol":"CELU"},"owners":[{"id":122283,"kind":"person","name":"Jones Anne","position":1,"cik":"0001869584","reported_name":"Jones Anne","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Class A Common Stock","published_at":"2022-11-18T20:16:41.000Z","date":"2022-11-16","kind":"tax_withholding","acquired":false,"shares":3734,"price":1.89,"value":7057.26,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Represents shares withheld by the Issuer to cover withholding taxes associated with the vesting and settlement of RSUs granted under the 2021 Plan and does not represent a sale."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"Includes 40,388 shares underlying RSUs granted under the 2021 Plan. Each RSU represents the right to receive one share of the Issuer's Class A common stock subject to vesting."}],"balance_after":49154,"source":{"system":"sec-edgar","filing":"0000899243-22-036454","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1869584/000089924322036454/doc4.xml","form_type":"4"}},{"id":2111008,"issuer":{"id":7145,"kind":"organization","name":"Celularity Inc","symbol":"CELU"},"owners":[{"id":122283,"kind":"person","name":"Jones Anne","position":1,"cik":"0001869584","reported_name":"Jones Anne","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Class A Common Stock","published_at":"2022-11-18T20:16:41.000Z","date":"2021-11-16","kind":"grant","acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares represent restricted stock units (\"RSUs\") granted under the Celularity Inc. 2021 Equity Incentive Plan (the \"2021 Plan\"), with each RSU representing a right to receive one share of the Issuer's Class A common stock.  The RSUs is subject to time-based vesting over a two-year period, with 50% vesting on the one-year anniversary of the grant date, and the remainder vesting on the two-year anniversary of the grant date so that vested in full on the two-year anniversary of the grant date, and subject to the Reporting Person's continuous service on each vesting date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Represents 52,888 shares underlying RSUs granted under the 2021 Plan. Each RSU represents the right to receive one share of the Issuer's Class A common stock subject to vesting."}],"balance_after":52888,"source":{"system":"sec-edgar","filing":"0000899243-22-036454","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1869584/000089924322036454/doc4.xml","form_type":"4"}},{"id":2207279,"issuer":{"id":7145,"kind":"organization","name":"Celularity Inc","symbol":"CELU"},"owners":[{"id":122283,"kind":"person","name":"Jones Anne","position":1,"cik":"0001869584","reported_name":"Jones Anne","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-07-15T20:46:09.000Z","date":"2022-07-13","kind":"grant","acquired":true,"shares":33670,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option was granted under the 2021 Plan and shall vest and become exercisable over a four-year period, with 25% of the option vesting on April 13, 2023, and the remainder vesting in equal monthly installments thereafter so that vested in full on April 13, 2026, and subject to the Reporting Person's continuous service on each vesting date."}],"balance_after":33670,"derivative":{"exercise_price":10.16,"expiration_date":"2032-07-13","underlying":"Class A Common Stock","underlying_shares":33670},"source":{"system":"sec-edgar","filing":"0000899243-22-026190","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1869584/000089924322026190/doc4.xml","form_type":"4"}},{"id":2207278,"issuer":{"id":7145,"kind":"organization","name":"Celularity Inc","symbol":"CELU"},"owners":[{"id":122283,"kind":"person","name":"Jones Anne","position":1,"cik":"0001869584","reported_name":"Jones Anne","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Class A Common Stock","published_at":"2022-07-15T20:46:09.000Z","date":"2022-07-13","kind":"grant","acquired":true,"shares":11483,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares represent restricted stock units (\"RSUs\") granted under the Celularity Inc. 2021 Equity Incentive Plan (the \"2021 Plan\"), with each RSU representing a right to receive one share of the Issuer's Class A common stock.  The RSUs is subject to time-based vesting over a four-year period, with 25% vesting on the one-year anniversary of the grant date, and the remainder vesting in equal annual installments thereafter so that vested in full on the four-year anniversary of the grant date, and subject to the Reporting Person's continuous service on each vesting date."}],"balance_after":27888,"source":{"system":"sec-edgar","filing":"0000899243-22-026190","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1869584/000089924322026190/doc4.xml","form_type":"4"}},{"id":2289085,"issuer":{"id":7145,"kind":"organization","name":"Celularity Inc","symbol":"CELU"},"owners":[{"id":122283,"kind":"person","name":"Jones Anne","position":1,"cik":"0001869584","reported_name":"Jones Anne","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-04-28T20:52:54.000Z","date":"2022-04-13","kind":"grant","acquired":true,"shares":48100,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option shall vest and become exercisable over a four-year period, with 25% of the option vesting on the one-year anniversary of the grant date, and the remainder vesting in equal monthly installments thereafter so that vested in full on the four-year anniversary of the grant date, and subject to the Reporting Person's continuous service on each vesting date."}],"balance_after":48100,"derivative":{"exercise_price":10.16,"expiration_date":"2032-04-13","underlying":"Class A Common Stock","underlying_shares":48100},"source":{"system":"sec-edgar","filing":"0000899243-22-015901","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1869584/000089924322015901/doc4.xml","form_type":"4"}},{"id":2289084,"issuer":{"id":7145,"kind":"organization","name":"Celularity Inc","symbol":"CELU"},"owners":[{"id":122283,"kind":"person","name":"Jones Anne","position":1,"cik":"0001869584","reported_name":"Jones Anne","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Class A Common Stock","published_at":"2022-04-28T20:52:54.000Z","date":"2022-04-13","kind":"grant","acquired":true,"shares":16405,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"These shares represent restricted stock units (\"RSUs\") granted under the Celularity Inc. 2021 Plan, with each RSU representing a right to receive one share of the Issuer's Class A Common Stock.  The RSUs is subject to time-based vesting over a four-year period, with 25% vesting on the one-year anniversary of the grant date, and the remainder vesting in equal annual installments thereafter so that vested in full on the four-year anniversary of the grant date, and subject to the Reporting Person's continuous service on each vesting date."}],"balance_after":16405,"source":{"system":"sec-edgar","filing":"0000899243-22-015901","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1869584/000089924322015901/doc4.xml","form_type":"4"}},{"id":2629633,"issuer":{"id":7145,"kind":"organization","name":"Celularity Inc","symbol":"CELU"},"owners":[{"id":122283,"kind":"person","name":"Jones Anne","position":1,"cik":"0001869584","reported_name":"Jones Anne","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-07-20T21:19:09.000Z","date":"2021-07-16","kind":"grant","acquired":true,"shares":96074,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Pursuant to the Merger Agreement and Plan of Merger and Reorganization, dated January 8, 2021 (the \"Business Combination Agreement\"), by and among GX Acquisition Corp. (\"GX\"), Alpha First Merger Sub Corp., Celularity LLC and Celularity Inc. (\"Legacy Celularity\"), each security to purchase shares of Legacy Celularity common stock issued and outstanding immediately prior to the effective time of the transactions contemplated by the Business Combination Agreement was automatically converted into a security to purchase a number of shares of the Issuer's common stock based on a 1-to-0.768594024295126 conversion ratio. Upon consummation of the business combination, GX changed its name to \"Celularity Inc.\""},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option shall vest and become exercisable over a period of four years from the Vesting Start Date, April 26, 2021, with 25% vesting on the one year anniversary of the Vesting Start Date, and the remainder vesting over a period of 36 months thereafter, subject to the Reporting Person's continuous service with the Issuer on each such date."}],"balance_after":96074,"derivative":{"exercise_price":10.21,"expiration_date":"2031-07-16","underlying":"Class A Common Stock","underlying_shares":96074},"source":{"system":"sec-edgar","filing":"0001209191-21-047514","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1869584/000120919121047514/doc4.xml","form_type":"4"}}]}